LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Bladder Cancer|Breast Cancer|Colorectal Cancer|Lung Cancer|Ovarian Cancer|Pancreatic Cancer
Interventions: BIOLOGICAL: LMB-9 immunotoxin
Sponsor: University of Maryland, Baltimore
Collaborators: National Cancer Institute (NCI)